NuCana plc (NCNA)
NASDAQ: NCNA · Real-Time Price · USD
1.240
-0.080 (-6.06%)
At close: Jul 9, 2026, 4:00 PM EDT
1.250
+0.010 (0.81%)
After-hours: Jul 9, 2026, 7:52 PM EDT
NuCana Market Cap
NuCana has a market cap or net worth of $5.16 million as of July 9, 2026. Its market cap has increased by 932.14% in one year.
Market Cap
5.16M
Enterprise Value
-22.37M
1-Year Change
932.14%
Ranking
Category
Stock Price
$1.24
Market Cap Chart
Since September 28, 2017, NuCana's market cap has decreased from $513.70M to $5.16M, a decrease of -99.00%. That is a compound annual growth rate of -40.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 5.16M | -65.60% |
| Dec 31, 2025 | 15.00M | 219.15% |
| Dec 31, 2024 | 4.70M | -69.87% |
| Dec 29, 2023 | 15.60M | -54.65% |
| Dec 30, 2022 | 34.40M | -72.30% |
| Dec 31, 2021 | 124.20M | -21.19% |
| Dec 31, 2020 | 157.60M | -19.84% |
| Dec 31, 2019 | 196.60M | -57.38% |
| Dec 31, 2018 | 461.30M | 43.44% |
| Dec 29, 2017 | 321.60M | -37.40% |
| Sep 28, 2017 | 513.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pulmatrix | 6.03M |
| Genprex | 5.97M |
| Curanex Pharmaceuticals | 5.96M |
| BioAtla | 5.96M |
| Acurx Pharmaceuticals | 5.84M |
| Cardio Diagnostics Holdings | 5.71M |
| Dermata Therapeutics | 5.69M |
| Aptevo Therapeutics | 5.56M |